The “Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.
The global dry eye syndrome market reached a value of US$ 4.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 6 Billion by 2027, exhibiting a CAGR of 5.95% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person’s eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Various diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient’s blood which adversely affects the tear glands resulting in a rising prevalence of dry eye.
Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being, Akorn Inc., Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd. and Santen Pharmaceutical Co. Ltd.
Key Questions Answered in this Report
- What was the size of the global dry eye syndrome market in 2021?
- What is the expected growth rate of the global dry eye syndrome market during 2022-2027?
- What are the key factors driving the global dry eye syndrome market?
- What has been the impact of COVID-19 on the global dry eye syndrome market?
- What is the breakup of the global dry eye syndrome market based on the disease type?
- What is the breakup of the global dry eye syndrome market based on the drug type?
- What is the breakup of the global dry eye syndrome market based on the product?
- What is the breakup of the global dry eye syndrome market based on the distribution channel?
- What are the key regions in the global dry eye syndrome market?
- Who are the key companies/players in the global dry eye syndrome market?
This article was shared with Prittle Prattle News as a Press Release by PRNewswire
